<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-04-30-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>0720-AB54</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>201110</PUBLICATION_ID>
            <PUBLICATION_TITLE>The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>0720</CODE>
            <NAME>Office of Assistant Secretary for Health Affairs</NAME>
            <ACRONYM>DODOASHA</ACRONYM>
        </AGENCY>
        <PARENT_AGENCY>
            <CODE>0700</CODE>
            <NAME>Department of Defense</NAME>
            <ACRONYM>DOD</ACRONYM>
        </PARENT_AGENCY>
        <RULE_TITLE>TRICARE; Removal of the Prohibition to Use Addictive Drugs in the Maintenance Treatment of Substance Dependence in TRICARE Beneficiaries</RULE_TITLE>
        <ABSTRACT><![CDATA[This rule proposes revisions to the Code of Federal Regulations (CFR) title 32 section 199.4(e) to remove the exclusion of drug abuse maintenance programs and allow as part of a comprehensive treatment plan for an individual with substance dependence, the substitution of a therapeutic drug with addictive potential for a drug of addiction (e.g. the substitution of methadone for heroin).   The current regulation prohibits drug maintenance programs where one addictive substance is substituted for another.  However, this prohibition of maintenance treatment of substance dependence utilizing a specific category of psychoactive agent is outdated and fails to recognize the accumulated medical evidence supporting certain maintenance programs as one component of the continuum of care necessary for the effective treatment of substance dependence. Current medical evidence shows that this is medically or psychologically necessary and integral to the safe and effective treatment of drug abuse as is generally required for all treatment benefits under 32 CFR 199.4(g)(15) for inclusion in the TRICARE benefit.]]></ABSTRACT>
        <PRIORITY_CATEGORY>Substantive, Nonsignificant</PRIORITY_CATEGORY>
        <RIN_STATUS>First Time Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Proposed Rule Stage</RULE_STAGE>
        <MAJOR>No</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <CFR_LIST>
            <CFR>32 CFR 199</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>5 USC 301</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>10 USC ch 55</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST/>
        <RPLAN_ENTRY>No</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>NPRM</TTBL_ACTION>
                <TTBL_DATE>12/00/2011</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <RFA_REQUIRED>No</RFA_REQUIRED>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>None</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FEDERALISM>No</FEDERALISM>
        <ENERGY_AFFECTED>No</ENERGY_AFFECTED>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Patricia</FIRST_NAME>
                <LAST_NAME>Toppings</LAST_NAME>
                <MIDDLE_NAME>Lynn</MIDDLE_NAME>
                <TITLE>Director, Regulatory Directorate</TITLE>
                <AGENCY>
                    <CODE>0700</CODE>
                    <NAME>Department of Defense</NAME>
                    <ACRONYM>DOD</ACRONYM>
                </AGENCY>
                <PHONE>571 372-0485</PHONE>
                <FAX>571 372-0487</FAX>
                <EMAIL>patricia.l.toppings.civ@mail.mil</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>DIOR\ICD, 4800 Mark Center Drive, East Tower, Suite 08F07,</STREET_ADDRESS>
                    <CITY>Alexandria</CITY>
                    <STATE>VA</STATE>
                    <ZIP>22350-3100</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
